Aiman Ozhikenova

Dr. Aiman Ozhikenova


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2025 in Sensors
Verified
Journal Article
Open access
PDF file
BABeibit Abdikenov
Beibit Abdikenov
DZDarkhan Zholtayev
Darkhan Zholtayev
KSKanat Suleimenov
Kanat Suleimenov
NANazgul Assan
Nazgul Assan
KOKassymbek Ozhikenov
Kassymbek Ozhikenov
AKAkim Kapsalyamov
Akim Kapsalyamov
Hands are central to nearly every aspect of daily life, so losing an upper limb due to amputation can severely affect a person’s independence. Robotic prostheses offer a promising solution by mimicking many of the functions of a natural arm, leading to an increasing need for advanced prosthetic designs. However, developing an effective robotic hand prosthesis is far from straightforward. It involves several critical steps, including creating accurate models, choosing materials that balance biocompatibility with durability, integrating electronic and sensory components, and perfecting control systems before final production. A key factor in ensuring smooth, natural movements lies in the method of control. One popular approach is to use electromyography (EMG), which relies on electrical signals from the user’s remaining muscle activity to direct the prosthesis. By decoding these signals, we can predict the intended hand and arm motions and translate them into real-time actions. Recent strides in machine learning have made EMG-based control more adaptable, offering users a more intuitive experience. Alongside this, researchers are exploring tactile sensors for enhanced feedback, materials resilient in harsh conditions, and mechanical designs that better replicate the intricacies of a biological limb. This review brings together these advancements, focusing on emerging trends and future directions in robotic upper-limb prosthesis development.

16 November 2025 in Mathematics
Verified
Journal Article
Open access
PDF file
KSKanat Suleimenov
Kanat Suleimenov
AKAkim Kapsalyamov
Akim Kapsalyamov
BABeibit Abdikenov
Beibit Abdikenov
AOAiman Ozhikenova
Aiman Ozhikenova
IYIgembay Yerbolat
Igembay Yerbolat
KOKassymbek Ozhikenov
Kassymbek Ozhikenov
The control of tendon-driven robotic fingers presents significant challenges due to their inherent underactuation, coupled with complex non-linear dynamics arising from tendon elasticity, friction, and external disturbances. Therefore, achieving precise control of finger motion and contact interactions necessitates advanced modeling, estimation, and control strategies capable of addressing uncertainties in tendon tension, routing, and elasticity. This paper presents a comprehensive comparative study of three distinct control paradigms: feedback linearization with Proportional-Derivative (FBL-PD) control, feedback linearization with super-twisting sliding-mode algorithm (FBL-STA), and deep-deterministic reinforcement learning (DDPG-RL), for the precise trajectory tracking of a three-link tendon-driven robotic finger. Through extensive simulations, the performance of each controller is rigorously evaluated based on trajectory-tracking accuracy and robustness to varying disturbances. The results indicate that under disturbance-free conditions, the FBL-PD and FBL-STA controllers, when properly tuned, achieve precise tracking of the reference trajectory; however, they produce noticeably noisy control signals. When subjected to external disturbances, these controllers exhibit increased sensitivity, producing even noisier responses. In contrast, the DDPG-RL maintains smooth control dynamics and achieves sufficiently accurate tracking in both scenarios. This comparative analysis elucidates the strengths and weaknesses of each control strategy, offering critical insights and practical guidelines for the design and implementation of advanced control systems for dexterous tendon-driven robotic fingers.

27 May 2026 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Жадыра Нурдаулетовна АлимбаеваЖадыра Нурдаулетовна Алимбаева
Жадыра Нурдаулетовна Алимбаева
CAChingiz Alimbayev
Chingiz Alimbayev
KOKassymbek Ozhikenov
Kassymbek Ozhikenov
AOAiman Ozhikenova
Aiman Ozhikenova
USUssen Shylmyrza
Ussen Shylmyrza
KKKymbat Khaidarova
Kymbat Khaidarova
This structured critical review provides a comparative and analytically grounded overview of machine learning (ML) approaches for electrocardiography (ECG)-based detection of dysglycemia, with a specific focus on translational readiness for clinical screening. A structured literature search across PubMed, Scopus, Web of Science, and IEEE Xplore identified 183 records, of which 17 studies were included following predefined screening criteria and PRISMA-guided selection principles. The included studies demonstrate substantial heterogeneity in dataset size (ranging from 25,000 subjects), ECG acquisition modalities (single-lead, 12-lead, wearable), feature representations (raw signals, heart rate variability, engineered features), and ML strategies (classical algorithms, deep learning, and multimodal models). Reported model performance is generally high, with accuracy values frequently exceeding 0.85 and area under the curve (AUC) ranging from 0.78 to 0.99. Smaller experimental studies often report inflated performance (up to 96–99% accuracy), whereas large-scale population-based investigations demonstrate more moderate but clinically plausible results (AUC ≈ 0.80–0.85). External validation, a key requirement for clinical applicability, was performed in only a limited subset of studies (approximately 12%). From a physiological perspective, ML models exploit ECG alterations associated with dysglycemia, including reduced heart rate variability, QT interval prolongation, and changes in ventricular depolarization and repolarization dynamics. However, the relationship between metabolic dysfunction and ECG signals remains indirect. A key finding of this review is the mismatch between reported predictive performance and translational readiness. The majority of studies (≈65–70%) are classified as early-stage (Level 1–2 or 2–3), relying on small, single-center datasets and internal validation. Only a minority of studies achieve near-translational maturity (Level 4), characterized by large-scale datasets and external validation. ECG-based dysglycemia detection represents a promising non-invasive and scalable screening paradigm. However, its clinical translation is constrained by the lack of standardized ECG acquisition protocols, limited dataset diversity, insufficient external validation, and fragmented methodological approaches. Future research should prioritize large multi-center datasets, standardized feature extraction pipelines, hybrid interpretable models, and prospective validation to enable robust, generalizable, and clinically deployable screening systems.

30 August 2026 in Sensors
Verified
Journal Article
Open access
PDF file
Жадыра Нурдаулетовна АлимбаеваЖадыра Нурдаулетовна Алимбаева
Жадыра Нурдаулетовна Алимбаева
CAChingiz Alimbayev
Chingiz Alimbayev
KOKassymbek Ozhikenov
Kassymbek Ozhikenov
KKKairat Karibayev
Kairat Karibayev
AOAiman Ozhikenova
Aiman Ozhikenova
Akzhol NurdanaliAkzhol Nurdanali
Akzhol Nurdanali
Wearable electrocardiographic technologies have become increasingly important for continuous cardiac monitoring; however, most existing portable systems are limited by the number of recorded leads or provide only basic signal acquisition without advanced automated analysis. This study presents a third-generation wearable twelve-lead electrocardiographic platform developed for multilead ECG acquisition and automated spatial ECG analysis. Compared with the previous generation, the hardware modification primarily consists of architectural consolidation: functions previously distributed across an STM32 microcontroller and separate wireless communication modules are integrated into a single ESP32-S3-based architecture, while the ECG acquisition principle, ten-electrode configuration, and sampling rate remain unchanged. The main methodological contribution of the present work is the software pipeline for lead-specific ST80 measurement and analysis of ST-segment deviations across anatomically contiguous leads. The system uses an ADS1298 analog front-end for synchronized multichannel ECG acquisition. The host software performs digital preprocessing, R-peak detection, ECG feature extraction, twelve-lead reconstruction, lead-specific ST80 measurement, contiguous-lead analysis, and generation of a preliminary computer-assisted ECG report. The developed platform was clinically evaluated using sequential recordings acquired with the proposed system and a reference clinical electrocardiograph. Quantitative comparison of automated PR, QRS, QT, and QTc measurements in 30 paired recordings demonstrated positive correlations with the reference BTL Flexi 12 ECG (r = 0.756–0.820, all p < 0.001), with mean absolute errors ranging from 2.53 ms for QRS duration to 10.40 ms for the QT interval. The system successfully recorded diagnostically interpretable twelve-lead ECGs in all participants and produced stable signal quality suitable for clinical assessment. The software automatically identified ECG waves and intervals, reconstructed twelve-lead recordings, evaluated ST-segment deviations across individual leads, and localized ischemia-related changes according to standard anatomical lead groups. Integration of signal acquisition, processing, visualization, and automated interpretation into a single telemedicine-oriented platform reduced hardware complexity while maintaining reliable multichannel ECG monitoring. The proposed wearable platform demonstrates the feasibility of combining compact embedded hardware with automated multilead ECG analysis for remote cardiovascular monitoring. The presented architecture provides a practical foundation for telemedicine applications and may support earlier recognition of clinically significant electrocardiographic abnormalities during ambulatory monitoring.

27 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Жадыра Нурдаулетовна АлимбаеваЖадыра Нурдаулетовна Алимбаева
Жадыра Нурдаулетовна Алимбаева
CAChingiz Alimbayev
Chingiz Alimbayev
KOKassymbek Ozhikenov
Kassymbek Ozhikenov
AOAiman Ozhikenova
Aiman Ozhikenova
USUssen Shylmyrza
Ussen Shylmyrza
KKKymbat Khaidarova
Kymbat Khaidarova
This systematic review provides a comprehensive and quantitatively grounded synthesis of machine learning (ML) approaches for electrocardiography (ECG)-based detection of dysglycemia, with a specific focus on translational readiness for clinical screening. A structured literature search across PubMed, Scopus, Web of Science, and IEEE Xplore (February 2025) identified 183 records, of which 17 studies met predefined inclusion criteria following PRISMA-guided screening. The included studies demonstrate substantial heterogeneity in dataset size (ranging from 25,000 subjects), ECG acquisition modalities (single-lead, 12-lead, wearable), feature representations (raw signals, heart rate variability, engineered features), and ML strategies (classical algorithms, deep learning, and multimodal models). Reported model performance is generally high, with accuracy values frequently exceeding 0.85 and area under the curve (AUC) ranging from 0.78 to 0.99. Smaller experimental studies often report inflated performance (up to 96–99% accuracy), whereas large-scale population-based investigations demonstrate more moderate but clinically plausible results (AUC ≈ 0.80–0.85). External validation, a key requirement for clinical applicability, was performed in only a limited subset of studies (approximately 12%). From a physiological perspective, ML models exploit ECG alterations associated with dysglycemia, including reduced heart rate variability, QT interval prolongation, and changes in ventricular depolarization and repolarization dynamics. However, the relationship between metabolic dysfunction and ECG signals remains indirect. A key finding of this review is the mismatch between reported predictive performance and model maturity. The majority of studies (≈65–70%) are classified as early-stage (Level 1–2 or 2–3), relying on small, single-center datasets and internal validation. Only a minority of studies achieve near-translational maturity (Level 4), characterized by large-scale datasets and external validation. ECG-based dysglycemia detection represents a promising non-invasive and scalable screening paradigm. However, its clinical translation is constrained by the lack of standardized ECG acquisition protocols, limited dataset diversity, insufficient external validation, and fragmented methodological frameworks. Future research should prioritize large multi-center datasets, standardized feature extraction pipelines, hybrid interpretable models, and prospective validation to enable robust, generalizable, and clinically deployable screening systems.

6 May 2026 in Algorithms
Verified
Journal Article
Open access
PDF file
Жадыра Нурдаулетовна АлимбаеваЖадыра Нурдаулетовна Алимбаева
Жадыра Нурдаулетовна Алимбаева
CAChingiz Alimbayev
Chingiz Alimbayev
KOKassymbek Ozhikenov
Kassymbek Ozhikenov
KKKairat Karibayev
Kairat Karibayev
AOAiman Ozhikenova
Aiman Ozhikenova
DADilfuza Akhmedova
Dilfuza Akhmedova
The aim of this study was to evaluate the feasibility of predicting percutaneous coronary intervention (PCI) based on clinical, laboratory, and electrocardiographic data available at various stages of hospitalization. A retrospective single-center study was conducted, including 137 patients with suspected coronary artery disease. The fact that PCI was performed during the current hospitalization was considered as the endpoint. Taking into account the temporary availability of data, three sets of signs were formed: basic (SAFE), including indicators available at admission; clinical (CLINICAL); and extended (EXTENDED), supplemented with glycemic parameters. Logistic regression, random forest, and gradient boosting were used to build the models. The assessment was carried out using repeated stratified cross-validation (5 × 10). The main metrics were ROC-AUC, PR-AUC, accuracy and F1-measure. The models demonstrated moderate predictive ability. The basic model (SAFE) showed a ROC-AUC of 0.734 ± 0.092, while the best results were achieved using an extended model based on a random forest (ROC-AUC 0.755 ± 0.079). The addition of glycemic parameters provided a moderate improvement in prediction quality. In the logistic regression, the most significant predictor was the presence of type 2 diabetes mellitus (OR = 7.36; p < 0.001). The results indicate the potential for using non-invasive data to assess the likelihood of PCI in the early stages of hospitalization. However, the models show moderate accuracy and require further validation on larger and more independent samples.